Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The
availability of prophylactic vaccines for high-risk types of human papillomavirus (HPV) …

COVID-19 has disrupted cervical screening in several countries, due to a range of policy-,
health-service and participant-related factors. Using three well-established models of …

Background HPV vaccine can block the infection of high-risk human papillomavirus and is
an important measure to effectively reduce the incidence of cervical cancer and …

Background Cervical cancer incidence is high in Kenya due to HIV and limited access to
cancer prevention services. Human papillomavirus (HPV) has been shown to increase HIV …

Background To eliminate cervical cancer as a public health problem, the World Health
Organization had recommended routine vaccination of adolescent girls with two doses of the …

Simple Summary HPV vaccination protects against virus that may cause cervical cancer.
Opportunistic HPV vaccination (ie, vaccination at a citizens' own initiative and cost) has been …

Background Human papillomavirus (HVP)–positive oropharyngeal cancer is the most
common HPV-associated cancer in the United States. The age at acquisition of oral HPV …

Background The 2021 Chinese Expert Consensus on the Clinical Application of the Human
Papillomavirus (HPV) Vaccine recommended vaccination for women who previously …